Seek above buy price
Seek's share price has recently jumped above the buy price. So what should you do?
Letting go of The Reject Shop
Australia's largest discount variety retailer is undergoing a turnaround, but we're ready to move on.
Macquarie buys Esanda and upgrades again
Macquarie has bought the Esanda vehicle finance business from ANZ and upgraded its guidance for the third time this financial year.
Veda agrees to Equifax bid
A small increase in the bid price has been enough to win Veda's directors over.
Flight Centre's ongoing evolution
It's no secret that Flight Centre's corporate travel business is growing fast. Less obvious is the potential elsewhere.
Flight Centre's ongoing evolution
It's no secret that Flight Centre's corporate travel business is growing fast. Less obvious is the potential elsewhere.
Origin's capital call
Origin's capital raising is part of a broader package to raise cash and lower debt. Is it enough?
iCar Asia: Q3 update
After an underwhelming second-quarter update, the third quarter showed iCar Asia accelerating again.
AFIC and Argo put a premium on expertise
With AFIC and Argo you only need to make one decision - is now a good time to buy?
Trimming our coverage list
Our coverage list naturally grows and needs a trim every now and again. On this occasion, it's a bit like taking Status Quo to the barber.
Origin's rights issue
Origin announced a series of measures to conserve cash along with an equity raising today.
Primary's shifting strategy
A change of leadership has prompted an encouraging strategy review at Australia's largest network of medical centres - but debt remains an issue.
Metcash's troubled turnaround
New management expects Metcash's transformation strategy to make 'significant progress' in 2016. Good luck with that.
Vocus to merge with M2
Another day, another deal in the telco sector. Gaurav Sodhi explains why this one makes sense.
Brickworks and Soul Patts: Result 2015
The building boom has finally made its way to Brickworks. Is it too late to buy?
Bitcoin Group on the block
Keep an eye on the canary in the Bitcoin mine - the air might be getting thin.
TPG's biggest byte
TPG is one of the most successful startups in Australian corporate history, but does that make it a great buy today?
Blackmores' bitter pill
Blackmores is an Australian healthcare success story. But potential industry changes and a high price mean investors should beware.
Blackmores' bitter pill
Blackmores is an Australian healthcare success story. But potential industry changes and a high price mean investors should beware.
Sydney Airport continues to rise
Sydney Airport's share price continues to rise but this is one stock we don't want to let go of too easily.
Is it worth punting on Baby Bunting?
Despite caution about its private equity roots, Baby Bunting could be worth a look.
Equifax bids for Veda
US credit reporting agency Equifax has swooped on Veda Group. It's time to play the waiting game.
Virtus Health's genetic goldmine
Genetic testing is quickly becoming big business for this IVF provider.
Call 1300 880 160
Start a chat
Schedule a call
